Tamás Jernei

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Molecular Docking

Oxide Nanoparticles

Breast Cancer Cells

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Antioxidants (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

António Dembo, Etelka Ferenczi, Tamás Jernei, Andrea Bor, Zsuzsanna Schelz, István Zupkó, Szilárd Varga, Antal Csámpai
CuAAC-Based Synthesis, Copper-Catalyzed Aldehyde-Forming Hydrolytic Fission and Antiproliferative Evaluation of Novel Ferrocenoylamino-Substituted Triazole-Tethered Quinine-Chalcone Hybrids. Molecules (Basel, Switzerland) 29 (2) (2024)
António Dembo, Etelka Ferenczi, Tamás Jernei, Andrea Bor, Zsuzsanna Schelz, István Zupkó, Szilárd Varga, Antal Csámpai
CuAAC-Based Synthesis, Copper-Catalyzed Aldehyde-Forming Hydrolytic Fission and Antiproliferative Evaluation of Novel Ferrocenoylamino-Substituted Triazole-Tethered Quinine-Chalcone Hybrids. Molecules (Basel, Switzerland) 29 (2) (2024)
António Dembo, Etelka Ferenczi, Tamás Jernei, Andrea Bor, Zsuzsanna Schelz, István Zupkó, Szilárd Varga, Antal Csámpai
CuAAC-Based Synthesis, Copper-Catalyzed Aldehyde-Forming Hydrolytic Fission and Antiproliferative Evaluation of Novel Ferrocenoylamino-Substituted Triazole-Tethered Quinine-Chalcone Hybrids. Molecules (Basel, Switzerland) 29 (2) (2024)
Márton Kalabay, Zsófia Szász, Orsolya Láng, Eszter Lajkó, Éva Pállinger, Cintia Duró, Tamás Jernei, Antal Csámpai, Angéla Takács, László Kőhidai
Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Cintia Duró, Tamás Jernei, Krisztina J Szekeres, Győző G Láng, Rita Oláh-Szabó, Szilvia Bősze, Ildikó Szabó, Ferenc Hudecz, Antal Csámpai
Synthesis and SAR Analysis of Novel 4-Hydroxytamoxifen Analogues Based on Their Cytotoxic Activity and Electron-Donor Character. Molecules (Basel, Switzerland) 27 (19) (2022)
Ahmed Dhahir Latif, Tamás Jernei, Ana Podolski-Renić, Ching-Ying Kuo, Máté Vágvölgyi, Gábor Girst, István Zupkó, Sedef Develi, Engin Ulukaya, Hui-Chun Wang, Milica Pesic, Antal Csámpai, Attila Hunyadi
Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling. Antioxidants (Basel, Switzerland) 9 (6) (2020)